Talk:Sinopharm WIBP COVID-19 vaccine
| This is the talk page for discussing improvements to the Sinopharm WIBP COVID-19 vaccine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
 | On 12 August 2021, it was proposed that this article be moved to Sinopharm COVID-19 vaccine WIBP. The result of the discussion was Moved to Sinopharm BIBP COVID-19 vaccine and Sinopharm WIBP COVID-19 vaccine. |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
.svg){kind=small}
Move discussion in progress
[edit]There is a move discussion in progress on Talk:BBIBP-CorV which affects this page. Please participate on that page and not in this talk page section. Thank you. —RMCD bot 03:09, 20 August 2021 (UTC)